Literature DB >> 27639120

Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults.

Julia A Scott1, Meredith N Braskie2, Duygu Tosun3, Pauline Maillard4, Paul M Thompson2, Michael Weiner3, Charles DeCarli4, Owen T Carmichael5.   

Abstract

Cross-sectional studies show that elevated cerebral amyloid is associated with greater white-matter hyperintensity (WMH) burden in cognitively normal (CN) older adults. However, the relative time courses of amyloid and WMH accrual are unclear. To address this, we tested the associations between known WMH correlates-age, hypertension, and amyloid-with WMH accrual rate. We used brain magnetic resonance imaging to measure WMH change in 112 CN Alzheimer's Disease Neuroimaging Initiative (GO/2) participants over a 2-year period. A linear mixed effects model assessed baseline cerebrospinal fluid amyloid beta (Aβ) 1-42, hypertension, age, and their interactions, as predictors of greater WMH accrual. Greater amyloid burden was associated with greater WMH accrual over time. Those with hypertension showed a stronger association between greater amyloid burden and WMH accrual rate. Greater age was not significantly associated with greater WMH accrual in this model. Although the direction of the relationship cannot be tested in this model, CN individuals harboring cerebral amyloid had greater accrual of WMH over a 2-year period after accounting for hypertension and age. Impaired amyloid clearance and cerebral small vessel disease may both underlie the more rapid emergence of WM lesions. The role of cerebral amyloid burden in white-matter injury should thus be considered as a relevant factor when WMHs are detected clinically.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADNI; Amyloid; FLAIR; Hypertension; MRI; Normal aging

Mesh:

Substances:

Year:  2016        PMID: 27639120      PMCID: PMC5798609          DOI: 10.1016/j.neurobiolaging.2016.08.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  31 in total

1.  Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Michal Figurski; Els Coart; Kaj Blennow; Holly Soares; Adam J Simon; Piotr Lewczuk; Robert A Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2011-02-11       Impact factor: 17.088

2.  Periventricular and subcortical hyperintensities on magnetic resonance imaging. 'Rims, caps, and unidentified bright objects'.

Authors:  A Kertesz; S E Black; G Tokar; T Benke; T Carr; L Nicholson
Journal:  Arch Neurol       Date:  1988-04

3.  White matter hyperintensities and their penumbra lie along a continuum of injury in the aging brain.

Authors:  Pauline Maillard; Evan Fletcher; Samuel N Lockhart; Alexandra E Roach; Bruce Reed; Dan Mungas; Charles DeCarli; Owen T Carmichael
Journal:  Stroke       Date:  2014-04-29       Impact factor: 7.914

4.  A Novel Small Molecule Modulator of Amyloid Pathology.

Authors:  Mark A Lovell; Bert C Lynn; Shuling Fister; Melissa Bradley-Whitman; M Paul Murphy; Tina L Beckett; Christopher M Norris
Journal:  J Alzheimers Dis       Date:  2016-05-04       Impact factor: 4.472

5.  White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults.

Authors:  Brian T Gold; Zude Zhu; Christopher A Brown; Anders H Andersen; Mary Jo LaDu; Leon Tai; Greg A Jicha; Richard J Kryscio; Steven Estus; Peter T Nelson; Steve W Scheff; Erin Abner; Frederick A Schmitt; Linda J Van Eldik; Charles D Smith
Journal:  Neurobiol Aging       Date:  2014-05-02       Impact factor: 4.673

6.  Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study.

Authors:  Ophélia Godin; Christophe Tzourio; Pauline Maillard; Bernard Mazoyer; Carole Dufouil
Journal:  Circulation       Date:  2011-01-10       Impact factor: 29.690

Review 7.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.

Authors:  Alida A Gouw; Alexandra Seewann; Wiesje M van der Flier; Frederik Barkhof; Annemieke M Rozemuller; Philip Scheltens; Jeroen J G Geurts
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-09       Impact factor: 10.154

8.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

9.  Regional pattern of white matter microstructural changes in normal aging, MCI, and AD.

Authors:  D Y Lee; E Fletcher; O Martinez; M Ortega; N Zozulya; J Kim; J Tran; M Buonocore; O Carmichael; C DeCarli
Journal:  Neurology       Date:  2009-10-21       Impact factor: 9.910

10.  Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.

Authors:  Timothy M Hughes; Lewis H Kuller; Emma J M Barinas-Mitchell; Rachel H Mackey; Eric M McDade; William E Klunk; Howard J Aizenstein; Ann D Cohen; Beth E Snitz; Chester A Mathis; Steven T Dekosky; Oscar L Lopez
Journal:  Neurology       Date:  2013-10-16       Impact factor: 9.910

View more
  10 in total

1.  Clinically silent Alzheimer's and vascular pathologies influence brain networks supporting executive function in healthy older adults.

Authors:  Brian T Gold; Christopher A Brown; Jonathan G Hakun; Leslie M Shaw; John Q Trojanowski; Charles D Smith
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

Review 2.  Cerebral small vessel disease: neuroimaging markers and clinical implication.

Authors:  Xiaodong Chen; Jihui Wang; Yilong Shan; Wei Cai; Sanxin Liu; Mengyan Hu; Siyuan Liao; Xuehong Huang; Bingjun Zhang; Yuge Wang; Zhengqi Lu
Journal:  J Neurol       Date:  2018-10-05       Impact factor: 4.849

3.  Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.

Authors:  Konstantinos Arfanakis; Arnold M Evia; Sue E Leurgans; Luis F C Cardoso; Arman Kulkarni; Nabil Alqam; Lucas F Lopes; Diego Vieira; David A Bennett; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice.

Authors:  Anjanet Loon; Frank Zamudio; Awa Sanneh; Breanna Brown; Shayna Smeltzer; Milene L Brownlow; Zainuddin Quadri; Melinda Peters; Edwin Weeber; Kevin Nash; Daniel C Lee; Marcia N Gordon; Dave Morgan; Maj-Linda B Selenica
Journal:  Geroscience       Date:  2021-08-19       Impact factor: 7.713

5.  Heterogeneity of Cerebral White Matter Lesions and Clinical Correlates in Older Adults.

Authors:  Keun-Hwa Jung; Kimberly A Stephens; Kathryn M Yochim; Joost M Riphagen; Chan Mi Kim; Randy L Buckner; David H Salat
Journal:  Stroke       Date:  2021-01-07       Impact factor: 10.170

6.  White matter hypointensities and hyperintensities have equivalent correlations with age and CSF β-amyloid in the nondemented elderly.

Authors:  Ke Wei; Thao Tran; Karen Chu; Matthew T Borzage; Meredith N Braskie; Michael G Harrington; Kevin S King
Journal:  Brain Behav       Date:  2019-11-06       Impact factor: 3.405

7.  APOE-ε4 modulates the association among plasma Aβ42/Aβ40, vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults.

Authors:  Dai Shi; Siwei Xie; Anqi Li; Qingyong Wang; Hongbo Guo; Ying Han; Huaxi Xu; Wen-Biao Gan; Lei Zhang; Tengfei Guo
Journal:  Transl Psychiatry       Date:  2022-03-29       Impact factor: 6.222

8.  White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.

Authors:  Anja Soldan; Corinne Pettigrew; Yuxin Zhu; Mei-Cheng Wang; Abhay Moghekar; Rebecca F Gottesman; Baljeet Singh; Oliver Martinez; Evan Fletcher; Charles DeCarli; Marilyn Albert
Journal:  Neurology       Date:  2019-12-30       Impact factor: 9.910

9.  Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.

Authors:  Kirsty E McAleese; Lauren Walker; Sophie Graham; Elisa L J Moya; Mary Johnson; Daniel Erskine; Sean J Colloby; Madhurima Dey; Carmen Martin-Ruiz; John-Paul Taylor; Alan J Thomas; Ian G McKeith; Charles De Carli; Johannes Attems
Journal:  Acta Neuropathol       Date:  2017-06-21       Impact factor: 17.088

10.  Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.

Authors:  Kirsty E McAleese; Mohi Miah; Sophie Graham; Georgina M Hadfield; Lauren Walker; Mary Johnson; Sean J Colloby; Alan J Thomas; Charles DeCarli; David Koss; Johannes Attems
Journal:  Acta Neuropathol       Date:  2021-10-04       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.